New sickle cell therapies will be out of reach where they are needed most
The Food and Drug Administration’s approval Friday of two innovative gene therapy treatments for sickle cell anemia has brought a rare moment of hope and celebration to people with this agonizing blood disorder. But there is no clear path to the new therapies (unique treatments so effective in clinical trials that they have been hailed…